LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR‐346/KLF14 axis

YG Wang, J Liu, M Shi, FX Chen - Journal of cellular physiology, 2019 - Wiley Online Library
Long non‐coding RNAs (lncRNAs) are a class of regulatory noncoding RNAs. Emerging
evidence highlights the critical roles of lncRNAs in the progression of hepatocellular …

LncRNA FLVCR1‐AS1 acts as miR‐513c sponge to modulate cancer cell proliferation, migration, and invasion in hepatocellular carcinoma

K Zhang, Z Zhao, J Yu, W Chen, Q Xu… - Journal of cellular …, 2018 - Wiley Online Library
In the present study, we aimed to search for dysregulated lnRNAs in Hepatocellular
carcinoma (HCC) tissues, and analyze the relationship of its expression level with the …

CRP‑1 promotes the malignant behavior of hepatocellular carcinoma cells via activating epithelial‑mesenchymal transition and Wnt/β‑catenin signaling

S Lei, X Du, K Tan, X He, Y Zhu… - Experimental and …, 2023 - spandidos-publications.com
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. It has
been reported that cysteine rich protein 1 (CRP‑1) is dysregulated in several types of human …

HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein

Z Xu, L Liang, H Wang, T Li, M Zhao - Biochemical and biophysical …, 2003 - Elsevier
One of the most frequent allelic deletions in hepatocellular carcinoma (HCC) has been
found at chromosome 8p21–23. We reported here the identification and characterization of a …

Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma

Z Qin, B Xie, J Qian, X Ma, L Zhang, J Wei… - Frontiers in …, 2023 - frontiersin.org
Background Ribonucleotide reductase regulatory subunit M2 (RRM2) has been reported to
be an oncogene in some malignant tumors, such as lung adenocarcinoma, oral squamous …

A polymorphism at the microRNA binding site in the 3′ untranslated region of RYR3 is associated with outcome in hepatocellular carcinoma

C Peng, Z Guo, X Wu, X Zhang - OncoTargets and therapy, 2015 - Taylor & Francis
Objective MicroRNAs can bind to the 3′ untranslated regions (UTRs) of messenger RNAs,
where they interfere with the translation of targeting genes, thereby regulating cell …

[HTML][HTML] Downregulation of PRRX1 via the p53-dependent signaling pathway predicts poor prognosis in hepatocellular carcinoma

M Fan, J Shen, H Liu, Z Wen, J Yang… - Oncology …, 2017 - spandidos-publications.com
Abstract Paired-related homeobox 1 (PRRX1) has been identified as a novel molecule
associated with induction of epithelial-mesenchymal transition (EMT), acquisition of cancer …

Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11

X Zeng, K Chen, L Li, J Tian, W Ruan, Z Hu… - Free Radical Biology …, 2022 - Elsevier
Clear cell renal cell carcinoma (ccRCC) is a common kidney malignancy that is
characterized by poor prognosis. RNA-binding motif protein 15 (RBM15) has been identified …

Ribosomal protein RPL5 regulates colon cancer cell proliferation and migration through MAPK/ERK signaling pathway

H Zhang, J Liu, Q Dang, X Wang, J Chen, X Lin… - BMC Molecular and Cell …, 2022 - Springer
Background Abnormal expression of ribosomal proteins has an important regulatory effect
on the progression of cancer. RPL5 is involved in the progression of various malignancies …

LncRNA FENDRR upregulation promotes hepatic carcinoma cells apoptosis by targeting miR-362-5p via NPR3 and p38-MAPK pathway

G Qian, X Jin, L Zhang - Cancer biotherapy & radiopharmaceuticals, 2020 - liebertpub.com
Background: Abnormal long noncoding RNA FOXF1 adjacent noncoding developmental
regulatory RNA (FENDRR) expression has been discovered in multiple human cancers …